209 related articles for article (PubMed ID: 4793331)
21. Vasoconstrictor actions of delta8- and delta9-tetrahydrocannabinol in the rat.
Adams MD; Earnhardt JT; Dewey WL; Harris LS
J Pharmacol Exp Ther; 1976 Mar; 196(3):649-56. PubMed ID: 4606
[TBL] [Abstract][Full Text] [Related]
22. Effects of Δ⁹-tetrahydrocannabinol (THC) vapor inhalation in Sprague-Dawley and Wistar rats.
Taffe MA; Creehan KM; Vandewater SA; Kerr TM; Cole M
Exp Clin Psychopharmacol; 2021 Feb; 29(1):1-13. PubMed ID: 32297788
[TBL] [Abstract][Full Text] [Related]
23. Spinal mechanisms of delta 9-tetrahydrocannabinol-induced analgesia.
Smith PB; Martin BR
Brain Res; 1992 Apr; 578(1-2):8-12. PubMed ID: 1324767
[TBL] [Abstract][Full Text] [Related]
24. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis.
Darmani NA; Johnson JC
Eur J Pharmacol; 2004 Mar; 488(1-3):201-12. PubMed ID: 15044052
[TBL] [Abstract][Full Text] [Related]
25. Appetitive, antinociceptive, and hypothermic effects of vaped and injected Δ-9-tetrahydrocannabinol (THC) in rats: exposure and dose-effect comparisons by strain and sex.
Moore CF; Davis CM; Harvey EL; Taffe MA; Weerts EM
Pharmacol Biochem Behav; 2021 Mar; 202():173116. PubMed ID: 33493547
[TBL] [Abstract][Full Text] [Related]
26. Tolerance to the cardiovascular effects of delta9-tetrahydrocannabinol in the rat.
Adams MD; Chait LD; Earnhardt JT
Br J Pharmacol; 1976 Jan; 56(1):43-8. PubMed ID: 1252665
[TBL] [Abstract][Full Text] [Related]
27. Hypothermia induced by delta9-tetrahydrocannabinol in rats with electrolytic lesions of preoptic region.
Schmeling WT; Hosko MJ
Pharmacol Biochem Behav; 1976 Jul; 5(1):79-83. PubMed ID: 996043
[TBL] [Abstract][Full Text] [Related]
28. Inactivity of delta9-tetrahydrocannabinol in antidepressant screening tests.
Sofia RD; Kubena RK; Barry H
Psychopharmacologia; 1973 Jul; 31(2):121-30. PubMed ID: 4722206
[No Abstract] [Full Text] [Related]
29. Effects of delta9-tetrahydrocannabinol on neurotransmitter accumulation and release mechanisms in rat forebrain synaptosomes.
Johnson KM; Ho BT; Dewey WL
Life Sci; 1976 Aug; 19(3):347-56. PubMed ID: 957874
[No Abstract] [Full Text] [Related]
30. Tolerance to the effect of delta9-tetrahydrocannabinol in mice on intestinal motility, temperature and locomotor activity.
Anderson PF; Jackson DM; Chesher GB; Malor R
Psychopharmacologia; 1975 Jul; 43(1):31-6. PubMed ID: 1161992
[TBL] [Abstract][Full Text] [Related]
31. A comparison of some pharmacological actions of morphine and delta9-tetrahydrocannabinol in the mouse.
Bloom AS; Dewey WL
Psychopharmacology (Berl); 1978 May; 57(3):243-8. PubMed ID: 97703
[TBL] [Abstract][Full Text] [Related]
32. The mechanism of action of delta 9-tetrahydrocannabinol on body temperature in mice.
Davies JA; Graham JD
Psychopharmacology (Berl); 1980; 69(3):299-305. PubMed ID: 6251505
[TBL] [Abstract][Full Text] [Related]
33. Acute and subchronic influences of tetrahydrocannabinols on water and food intake, body weight, and temperature in rats.
Johansson JO; Jarbe TU; Henriksson BG
TIT J Life Sci; 1975; 5(1-2):17-27. PubMed ID: 1188935
[TBL] [Abstract][Full Text] [Related]
34. Delta9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice.
Varvel SA; Bridgen DT; Tao Q; Thomas BF; Martin BR; Lichtman AH
J Pharmacol Exp Ther; 2005 Jul; 314(1):329-37. PubMed ID: 15831444
[TBL] [Abstract][Full Text] [Related]
35. The effect of selective inhibitors of noradrenaline and serotonin uptake on reserpine- and apomorphine induced hypothermia in mice.
Maj J; Rogóz Z; Skuza G; Sowińska H
Pol J Pharmacol Pharm; 1983; 35(1):49-57. PubMed ID: 6604264
[TBL] [Abstract][Full Text] [Related]
36. Effect of reserpine on N-methylthiobenzamide-induced pulmonary edema: role of lung norepinephrine and hypothermia.
Gibbs LS; Traiger GJ
Toxicology; 1989 Mar; 54(3):311-21. PubMed ID: 2495583
[TBL] [Abstract][Full Text] [Related]
37. The thermogenic actions of alpha 2-adrenoceptor agonists in reserpinized mice are mediated via a central postsynaptic alpha 2-adrenoceptor mechanism.
Bill DJ; Hughes IE; Stephens RJ
Br J Pharmacol; 1989 Jan; 96(1):133-43. PubMed ID: 2564288
[TBL] [Abstract][Full Text] [Related]
38. Reversal by L-threo-3,4-dihydroxyphenylserine (L-threo-DOPS), a L-norepinephrine precursor of reserpine- or tetrabenazine-induced hypothermia.
Katsuyama M; Kato T; Karai N; Nakamura M; Katsube J
Arch Int Pharmacodyn Ther; 1986 Sep; 283(1):61-70. PubMed ID: 3099671
[TBL] [Abstract][Full Text] [Related]
39. Tetrahydrocannabinol potentiates reserpine-induced hypokinesia.
Moss DE; McMaster SB; Rogers J
Pharmacol Biochem Behav; 1981 Nov; 15(5):779-83. PubMed ID: 6273940
[TBL] [Abstract][Full Text] [Related]
40. The effect of delta 9-tetrahydrocannabinol (delta 9-THC) on the turnover rate of brain serotonin of the rat.
Taylor DA; Fennessy MR
Clin Exp Pharmacol Physiol; 1979; 6(3):327-34. PubMed ID: 466871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
